A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer

The immunohistochemical determination of HER-2 to identify patients with advanced breast cancer candidates for Trastuzumab treatment proved neither accurate nor fully reliable, possibly because none of the current reagents detects the specific antigenic site target of Trastuzumab. To circumvent this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bussolati, G, Montemurro, F, Righi, L, Donadio, M, Aglietta, M, Sapino, A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2005
Gaiak:
Molecular Diagnostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361978/
https://ncbi.nlm.nih.gov/pubmed/15812476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602507
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak